COMPARE · Data as of August 24, 2026
AXTA vs STDN
Verdict: Side-by-side breakdown using the Bull Rankings model. AXTA scored 56.0, STDN scored 44.8 — AXTA leads.
Compare another set
AXTA
Axalta Coating Systems Ltd.
56
$36.06 · $7.7B
fundamentals as of
Score gap
11.2
AXTA leads
STDN
Standard Nuclear, Inc.
44.8
$11.94 · $1.9B
At a glance · who leads each dimension, on the model's own rules
- Fastest growthSTDN+57.1%
- Highest qualityAXTA65 / 100
Side by side · every name on one set of axes
The model, pillar by pillar (0–100 each)
AXTA
stronger →← stronger
STDN
65
Qualityreturns · margins · balance sheet
45
44
Growthrevenue & earnings expansion
50
61
Valuevaluation vs sector peers
40
AXTA is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
AXTA
STDN
$488mC
FCF
—
-2.6%D+
Rev
+57.1%A
1.19C
D/E
—
22.3xB
P/E
—
2.04C
PEG
—
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
AXTA
STDN
15% above
Price vs fair valuelower is cheaper
—
~9%/yr
Growth the price implies10-yr FCF · lower = less priced in
—
-18%
1-yr DCF upside
—
-13%
5-yr DCF upside
—
-6%
10-yr DCF upside
—
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
AXTA
Why this score
- Buying back stock
STDN
Why this score
- Cyclical growth
- Short track record
The companies
AXTAAxalta Coating Systems Ltd.
Why now
Specialty Chemicals · market cap $7.7b. 7% off the 52-week high of $38.61. 14 sell-side analysts publish a mean 1-yr target of $38.57 (implying +7% upside).
Moat
ROE 15% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 132% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
STDNStandard Nuclear, Inc.
Why now
Specialty Chemicals · market cap $1.9b. 15% off the 52-week high of $13.98. Revenue growing +57% — in hypergrowth territory. 8 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $16.00 (implying +34% upside).
Moat
Higher-variance name — the moat signals on the quantitative card are modest, so the durability case rests on execution (turning current growth into durable earnings power) or an un-monetized asset (IP / network effects / first-mover position) rather than an entrenched competitive position.
Risk
Higher-variance name — the thesis leans on growth and valuation rather than a long, settled track record, so it depends on execution continuing. Position size accordingly; a deep drawdown shouldn't change the thesis.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where AXTA and STDN diverge
On the headline score the gap is 11.2 points in favor of AXTA. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- ValueAXTA 61.3 · STDN 40.0AXTA +21.3
- QualityAXTA 64.5 · STDN 45.0AXTA +19.5
- GrowthAXTA 44.5 · STDN 50.0STDN +5.5
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.